Japan approves dexamethasone as coronavirus treatment


  • World
  • Wednesday, 22 Jul 2020

TOKYO (Reuters) - Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalised patients.

The ministry included dexamethasone as an option for treatment along with antiviral drug remdesivir in a recent revision to its handbook. The revision was widely reported by Japanese media on Wednesday.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Passenger plane flying from Azerbaijan to Russia crashes in Kazakhstan with many feared dead
South Korea's Yoon defies second agency summons over martial law
Multiple bird flu cases detected across England
Church of England must repent, leading cleric says at Christmas
Italy boosts security as 2025 Jubilee Year kicks off in Rome
U.S. stocks close higher
French officials raise Mayotte death toll to 39 after Storm Chido
Crude futures settle higher
Ukraine gets 1-bln-USD aid backed by frozen Russian assets
U.S. dollar ticks up

Others Also Read